Literature DB >> 15214921

A novel therapeutic option in pemphigus vulgaris: humanized monoclonal anti-CD25 antibody.

A Renkl, M Mockenhaupt, K Technau, Y Herouy, J Norgauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15214921     DOI： 10.1111/j.1365-2133.2004.05977.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

1.  Successful treatment of cerebral vasculitis in an HIV-positive patient with anti-CD25 treatment.

Authors:  C M G Nieuwhof; J Damoiseaux; J W Cohen Tervaert
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

Review 2.  Immunotherapy for Pemphigus: Present and Future.

Authors:  Huijie Yuan; Meng Pan; Hongxiang Chen; Xuming Mao
Journal:  Front Med (Lausanne)       Date:  2022-06-15

Review 3.  Pemphigus autoimmunity: hypotheses and realities.

Authors:  Sergei A Grando
Journal:  Autoimmunity       Date:  2011-09-23       Impact factor: 2.815
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.